Narvaiza Iñigo, Aparicio Oscar, Vera María, Razquin Nerea, Bortolanza Sergia, Prieto Jesús, Fortes Puri
Division of Gene Therapy and Hepatology, CIMA, University of Navarra, Pio XII 55, 31008 Pamplona, Spain.
J Virol. 2006 Dec;80(24):12236-47. doi: 10.1128/JVI.01205-06. Epub 2006 Oct 4.
RNA interference with viral vectors that express short hairpin RNAs (shRNAs) has emerged as a powerful tool for functional genomics and therapeutic purposes. However, little is known about shRNA in vivo processing, accumulation, functional kinetics, and side effects related to shRNA saturation of the cellular gene silencing machinery. Therefore, we constructed first-generation recombinant adenoviruses encoding different shRNAs against murine ATP-binding cassette multidrug resistance protein 2 (Abcc2), which is involved in liver transport of bilirubin to bile, and analyzed Abcc2 silencing kinetics. C57/BL6 mice injected with these viruses showed significant impairment of Abcc2 function for up to 3 weeks, as reflected by increased serum bilirubin levels. The lack of Abcc2 function correlated with a specific reduction of Abcc2 mRNA and with high levels of processed shRNAs targeting Abcc2. Inhibition was lost at longer times postinfection, correlating with a decrease in the accumulation of processed shRNAs. This finding suggests that a minimal amount of processed shRNAs is required for efficient silencing in vivo. This system was also used to evaluate the effect of shRNA expression on the saturation of silencing factors. Saturation of the cellular silencing processing machinery alters the accumulation and functionality of endogenous microRNAs (miRNAs) and pre-miRNAs. However, expression of functional exogenous shRNAs did not change the levels of endogenous miRNAs or their precursors. In summary, this work shows that adenoviral vectors can deliver sufficient shRNAs to mediate inhibition of gene expression without saturating the silencing machinery.
利用表达短发夹RNA(shRNA)的病毒载体进行RNA干扰已成为功能基因组学和治疗领域的强大工具。然而,关于shRNA在体内的加工、积累、功能动力学以及与细胞基因沉默机制的shRNA饱和相关的副作用,我们了解甚少。因此,我们构建了第一代重组腺病毒,其编码针对小鼠ATP结合盒多药耐药蛋白2(Abcc2)的不同shRNA,该蛋白参与胆红素向胆汁的肝脏转运,并分析了Abcc2的沉默动力学。注射这些病毒的C57/BL6小鼠在长达3周的时间内显示出Abcc2功能的显著受损,血清胆红素水平升高即反映了这一点。Abcc2功能的缺失与Abcc2 mRNA的特异性减少以及靶向Abcc2的高水平加工shRNA相关。感染后较长时间抑制作用消失,这与加工shRNA积累的减少相关。这一发现表明,在体内有效沉默需要最低量的加工shRNA。该系统还用于评估shRNA表达对沉默因子饱和的影响。细胞沉默加工机制的饱和会改变内源性微小RNA(miRNA)和前体miRNA的积累及功能。然而,功能性外源shRNA的表达并未改变内源性miRNA或其前体的水平。总之,这项工作表明腺病毒载体可以递送足够的shRNA来介导基因表达的抑制,而不会使沉默机制饱和。